Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Aug 1;175(8):817-826.
doi: 10.1001/jamapediatrics.2021.1050.

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

José Villar  1   2 , Shabina Ariff  3 , Robert B Gunier  4 , Ramachandran Thiruvengadam  5 , Stephen Rauch  4 , Alexey Kholin  6 , Paola Roggero  7   8 , Federico Prefumo  9   10 , Marynéa Silva do Vale  11 , Jorge Arturo Cardona-Perez  12 , Nerea Maiz  13 , Irene Cetin  14 , Valeria Savasi  15 , Philippe Deruelle  16 , Sarah Rae Easter  17   18 , Joanna Sichitiu  19 , Constanza P Soto Conti  20 , Ernawati Ernawati  21   22 , Mohak Mhatre  23 , Jagjit Singh Teji  24 , Becky Liu  25 , Carola Capelli  26 , Manuela Oberto  27 , Laura Salazar  28 , Michael G Gravett  29   30 , Paolo Ivo Cavoretto  31 , Vincent Bizor Nachinab  32 , Hadiza Galadanci  33   34 , Daniel Oros  35 , Adejumoke Idowu Ayede  36   37 , Loïc Sentilhes  38 , Babagana Bako  39 , Mónica Savorani  40 , Hellas Cena  41   42 , Perla K García-May  43 , Saturday Etuk  44 , Roberto Casale  45 , Sherief Abd-Elsalam  46 , Satoru Ikenoue  47 , Muhammad Baffah Aminu  48 , Carmen Vecciarelli  49 , Eduardo A Duro  50   51 , Mustapha Ado Usman  52 , Yetunde John-Akinola  36   37 , Ricardo Nieto  20 , Enrico Ferrazi  8 , Zulfiqar A Bhutta  53 , Ana Langer  54 , Stephen H Kennedy  1   2 , Aris T Papageorghiou  1   2   25
Affiliations
Comparative Study

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

José Villar et al. JAMA Pediatr. .

Erratum in

  • Misspelled Author Name in the Byline.
    [No authors listed] [No authors listed] JAMA Pediatr. 2022 Jan 1;176(1):104. doi: 10.1001/jamapediatrics.2021.4953. JAMA Pediatr. 2022. PMID: 34779828 Free PMC article. No abstract available.

Abstract

Importance: Detailed information about the association of COVID-19 with outcomes in pregnant individuals compared with not-infected pregnant individuals is much needed.

Objective: To evaluate the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with not-infected, concomitant pregnant individuals.

Design, setting, and participants: In this cohort study that took place from March to October 2020, involving 43 institutions in 18 countries, 2 unmatched, consecutive, not-infected women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. Women and neonates were followed up until hospital discharge.

Exposures: COVID-19 in pregnancy determined by laboratory confirmation of COVID-19 and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms.

Main outcomes and measures: The primary outcome measures were indices of (maternal and severe neonatal/perinatal) morbidity and mortality; the individual components of these indices were secondary outcomes. Models for these outcomes were adjusted for country, month entering study, maternal age, and history of morbidity.

Results: A total of 706 pregnant women with COVID-19 diagnosis and 1424 pregnant women without COVID-19 diagnosis were enrolled, all with broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Overweight early in pregnancy occurred in 323 women (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were at higher risk for preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27-2.43), severe infections (RR, 3.38; 95% CI, 1.63-7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13-8.10), maternal mortality (RR, 22.3; 95% CI, 2.88-172), preterm birth (RR, 1.59; 95% CI, 1.30-1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56-2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69-4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66-2.75). Fever and shortness of breath for any duration was associated with increased risk of severe maternal complications (RR, 2.56; 95% CI, 1.92-3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11-11.69). Asymptomatic women with COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00-1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01-2.63). Among women who tested positive (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18-3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66-1.85) was associated with increased risk for neonatal test positivity.

Conclusions and relevance: In this multinational cohort study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications when pregnant women with and without COVID-19 diagnosis were compared. The findings should alert pregnant individuals and clinicians to implement strictly all the recommended COVID-19 preventive measures.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Gunier reported grants from Oxford University during the conduct of the study. Dr Sentilhes reported personal, lecture, and consulting fees from Ferring Pharmaceutical and personal and lecture fees from Bayer outside the submitted work. Dr Papageorghiou reported grants from National Institute for Health Research Biomedical Research Centre and other support from Intelligent Ultrasound as director outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Gestational Age at Delivery Among Women With COVID-19 Diagnosis, With and Without Symptoms, and Women Without COVID-19 Diagnosis
There were 1420 women without COVID-19 diagnosis (dark blue). In the group of women with COVID-19 diagnosis, 417 women were symptomatic (light blue) and 288 women were asymptomatic (orange). There was a significant trend (P < .001) in shorter gestational age at delivery going from women without COVID-19 diagnosis, to asymptomatic women with COVID-19 diagnosis, to symptomatic women with COVID-19 diagnosis (log-rank test for trend of survivor curves). Five women with missing data were excluded from the figure.
See this image and copyright information in PMC

Comment in

Similar articles

  • Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study.
    Giuliani F, Oros D, Gunier RB, Deantoni S, Rauch S, Casale R, Nieto R, Bertino E, Rego A, Menis C, Gravett MG, Candiani M, Deruelle P, García-May PK, Mhatre M, Usman MA, Abd-Elsalam S, Etuk S, Napolitano R, Liu B, Prefumo F, Savasi V, Do Vale MS, Baafi E, Ariff S, Maiz N, Aminu MB, Cardona-Perez JA, Craik R, Tavchioska G, Bako B, Benski C, Hassan-Hanga F, Savorani M, Sentilhes L, Carola Capelli M, Takahashi K, Vecchiarelli C, Ikenoue S, Thiruvengadam R, Soto Conti CP, Cetin I, Nachinab VB, Ernawati E, Duro EA, Kholin A, Teji JS, Easter SR, Salomon LJ, Ayede AI, Cerbo RM, Agyeman-Duah J, Roggero P, Eskenazi B, Langer A, Bhutta ZA, Kennedy SH, Papageorghiou AT, Villar J. Giuliani F, et al. Am J Obstet Gynecol. 2022 Sep;227(3):488.e1-488.e17. doi: 10.1016/j.ajog.2022.04.019. Epub 2022 Apr 19. Am J Obstet Gynecol. 2022. PMID: 35452653 Free PMC article.
  • Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Villar J, Soto Conti CP, Gunier RB, Ariff S, Craik R, Cavoretto PI, Rauch S, Gandino S, Nieto R, Winsey A, Menis C, Rodriguez GB, Savasi V, Tug N, Deantoni S, Fabre M, Martinez de Tejada B, Rodriguez-Sibaja MJ, Livio S, Napolitano R, Maiz N, Sobrero H, Peterson A, Deruelle P, Giudice C, Teji JS, Casale RA, Salomon LJ, Prefumo F, Cheikh Ismail L, Gravett MG, Vale M, Hernández V, Sentilhes L, Easter SR, Capelli C, Marler E, Cáceres DM, Albornoz Crespo G, Ernawati E, Lipschuetz M, Takahashi K, Vecchiarelli C, Hubka T, Ikenoue S, Tavchioska G, Bako B, Ayede AI, Eskenazi B, Thornton JG, Bhutta ZA, Kennedy SH, Papageorghiou AT; INTERCOVID-2022 International Consortium. Villar J, et al. Lancet. 2023 Feb 11;401(10375):447-457. doi: 10.1016/S0140-6736(22)02467-9. Epub 2023 Jan 17. Lancet. 2023. PMID: 36669520 Free PMC article.
  • Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study.
    Barros FC, Gunier RB, Rego A, Sentilhes L, Rauch S, Gandino S, Teji JS, Thornton JG, Kachikis AB, Nieto R, Craik R, Cavoretto PI, Winsey A, Roggero P, Rodriguez GB, Savasi V, Kalafat E, Giuliani F, Fabre M, Benski AC, Coronado-Zarco IA, Livio S, Ostrovska A, Maiz N, Castedo Camacho FR, Peterson A, Deruelle P, Giudice C, Casale RA, Salomon LJ, Soto Conti CP, Prefumo F, Mohamed Elbayoumy EZ, Vale M, Hernández V, Chandler K, Risso M, Marler E, Cáceres DM, Crespo GA, Ernawati E, Lipschuetz M, Ariff S, Takahashi K, Vecchiarelli C, Hubka T, Ikenoue S, Tavchioska G, Bako B, Ayede AI, Eskenazi B, Bhutta ZA, Kennedy SH, Papageorghiou AT, Villar J; INTERCOVID-2022 International Consortium. Barros FC, et al. Am J Obstet Gynecol. 2024 Oct;231(4):460.e1-460.e17. doi: 10.1016/j.ajog.2024.02.008. Epub 2024 Feb 16. Am J Obstet Gynecol. 2024. PMID: 38367758
  • Differences in pregnancy and perinatal outcomes among symptomatic versus asymptomatic COVID-19-infected pregnant women: a systematic review and meta-analysis.
    Khan DSA, Hamid LR, Ali A, Salam RA, Zuberi N, Lassi ZS, Das JK. Khan DSA, et al. BMC Pregnancy Childbirth. 2021 Dec 1;21(1):801. doi: 10.1186/s12884-021-04250-1. BMC Pregnancy Childbirth. 2021. PMID: 34852783 Free PMC article.
  • Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
    Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V, D'Antonio F. Di Mascio D, et al. Am J Obstet Gynecol MFM. 2020 May;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107. Epub 2020 Mar 25. Am J Obstet Gynecol MFM. 2020. PMID: 32292902 Free PMC article.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wu Y, Zhang C, Liu H, et al. Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China. Am J Obstet Gynecol. 2020;223(2):240.e1-240.e9. doi: 10.1016/j.ajog.2020.05.009 - DOI - PMC - PubMed
    1. Davenport MH, Meyer S, Meah VL, Strynadka MC, Khurana R. Moms are not OK: COVID-19 and maternal mental health. Front Glob Womens Health. Published online June 19, 2020. doi: 10.3389/fgwh.2020.00001 - DOI - PMC - PubMed
    1. Yap M, Debenham L, Kew T, et al. ; PregCOV-19 Consortium . Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol. BMJ Open. 2020;10(12):e041868. doi: 10.1136/bmjopen-2020-041868 - DOI - PMC - PubMed
    1. Campbell KH, Tornatore JM, Lawrence KE, et al. Prevalence of SARS-CoV-2 among patients admitted for childbirth in southern Connecticut. JAMA. 2020;323(24):2520-2522. doi: 10.1001/jama.2020.8904 - DOI - PMC - PubMed
    1. Knight M, Bunch K, Vousden N, et al. ; UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group . Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369:m2107. doi: 10.1136/bmj.m2107 - DOI - PMC - PubMed